Request Sample Inquiry
Organs On Chips Market

Organs On Chips Market

Organs On Chips Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:


Base Year:



Jan - 2022



Report Code:


Segments Covered
  • By Type Liver, Heart, Lung, Other Organ Types
  • By Application Drug Discovery, Toxicology Research, Other Applications
  • By End User Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End Users
  • By Region Latin America, North America, Europe, Asia Pacific, Middle East & Africa
Forecast YearsForecast Years: 2021 - 2028
Historical YearsHistorical Years: 2016 - 2020
Revenue 2021Revenue 2021: USD 28.1 Million
Revenue 2028Revenue 2028: USD 125.7 Million
Revenue CAGRRevenue CAGR (2021 - 2028): 28.1%
Fastest Growing Region Fastest Growing Region (2021 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Organs on Chips Market Share

Market Synopsis:

Global Organs on Chips Market is valued at USD 28.1 Million in 2021 and is projected to attain a value of USD 125.7 Million by 2028 at a CAGR of 28.1% during the forecast period, 2022–2028. The growing focus on developing alternatives to animal testing models, a significant increase in research funding and venture capital investments for the development of Organs on Chips, technological advancements and new product launches, a growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and a growing need for early detection of drug toxicity to minimize financial costs are all driving the growth of Organs on Chips Market.

Organs on Chips Market Size, 2021 To 2028 (USD Million)

In the face of the COVID-19 pandemic, the scientific community and the biopharmaceutical sector have mobilised at breakneck speed. As a result, Organs on Chips has been established as one of the most promising and go-to technologies in the creation of vaccines and medications for the treatment of infection that are currently undergoing clinical trials. The imitate lung-chip, for example, was utilised to provide preclinical insights into the efficacy of hydroxychloroquine for COVID-19 in March 2020 as part of the World Health Organization's (WHO) Research and Development Blueprint response to the COVID-19 outbreak.

Advancements in Technology

Factors driving the Organs on Chips Market include the demand for alternatives to animal testing, the need for early identification of drug toxicity, as well as new product releases and technological breakthroughs. For example, in December 2020, CN Bio and the University of Melbourne worked to enhance respiratory complications therapy using lung-on-a-chip technology in patients who had recovered from COVID-19. Furthermore, in October 2020, BioVox launched an initiative to promote Organs on Chips technology as a means of improving in vitro research models and eliminating animal testing.

The demand for customised medicine and the wide range of applications for Organs on Chips technology outside of the pharmaceutical industry are two important reasons driving market expansion. The intricacy of Organs on Chips models, on the other hand, may stifle market growth over the foreseeable period.

Market Segmentation:

Global Organs on Chips Market is segmented by Organ Type (Liver, Heart, Lung, and Other Organ Types). Based on Application (Drug Discovery, Toxicology Research, and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End Users). Based on Region, the Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Below tree is interactive. You can click the nodes to get more information.

Lung Application is Expected to Grow Fastest During the Forecast Period

On a microchip, lung-on-chip technology is a complicated three-dimensional replica of a living, breathing human lung. This technology, which is made up of human lung and blood vessel cells, can predict nanoparticle absorption and simulate the inflammatory response induced by microbial infections. The device can also be used to assess environmental contaminants, aerosolized treatments absorption, and the safety and efficacy of novel medications. It is anticipated that it will become a viable alternative to animal experimentation. Lung-on-chip also offers an unique in vitro approach to drug screening by imitating the intricate mechanical and biochemical behaviours of a human lung, thanks to the combination of micro manufacturing techniques and contemporary tissue engineering.

North America Is Expected To Dominate the Market During The Forecast Period

North America is predicted to account for the greatest share of the market in 2020 and to grow at the fastest CAGR, followed by Europe. The availability of new and advanced Organs on Chips models in the market, favourable government initiatives in terms of funding and programmes for basic drug development and research, and the presence of key pharmaceutical companies are all factors that contribute to this market's large share and rapid growth.

Key Players:

Some key players operating in the market are Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), Ascendance Bio (US), CN Bio (UK), TissUse (Germany), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

Organs on Chips Market is segmented as follows:

Parameter Details
Segments Covered
  • Type (Liver, Heart, Lung, Other Organ Types)
  • Application (Drug Discovery, Toxicology Research, Other Applications)
  • End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End Users)
  • Region (Latin America, North America, Europe, Asia Pacific, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • AxoSim Inc.
  • BiomimX SRL
  • Elveflow
  • Emulate Inc.
  • Hurel Corporation
  • InSphero AG
  • Nortis Inc.
  • Tara Biosystems Inc.
  • and TissUse GmbH
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Organs on Chips Market is tabulated as follows:

Organs on Chips Market Projected to Reach USD 125.7 Million by 2028
The Organs on Chips Market is expected to reach USD 125.7 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 28.1% from 2022 to 2028. Factors such as increasing funding for venture capital & research activities in the development of organs-on-chips products, increasing technological...
Frequently Asked Question
  • The global Organs on Chips valued at in 2020 and is expected to reach in 2028 growing at a CAGR of 28.1%.

  • The prominent players in the market are AxoSim Inc., BiomimX SRL, Elveflow, Emulate Inc., Hurel Corporation, InSphero AG, MIMETAS BV, Nortis Inc., Tara Biosystems Inc., and TissUse GmbH.

  • The market is project to grow at a CAGR of 28.1% between 2021 and 2028.

  • The driving factors of the Organs on Chips include

    • Advancements in Technology

  • North America was the leading regional segment of the Organs on Chips in 2020.

Related Reports